Hematology and Oncology
About UsThe Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.
Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”
– William J. Gradishar, MD
What We Do
Faculty: Meet the Team
View individual profiles of our faculty members and learn about their research and clinical specialties.
Associate Professor of Medicine (Hematology and Oncology)
My clinical practice involves the medical treatment of breast cancer in women and men with a particular interest in young women with breast cancer. My clinical research endeavors involve chemotherapy, endocrine therapy, and novel therapies for the treatment of breast cancer. I am interested in ways to optimize and individualize breast cancer treatment based on patient characteristics as well as tumor specific molecular profiles.
Associate Professor of Neurology (Neuro-oncology) and Medicine (Hematology and Oncology)
Our research program is aimed at understanding the genetic program that underlies the pathogenesis of Glioblastoma multiforme (GBM), the most prevalent and malignant form of brain cancer. Applying a combination of cell/molecular biology, oncogenomic and mouse engineering approaches, we are dedicated to systematically characterize novel gliomagenic oncogenes and tumor suppressors. We will functionally delineate and validate these pathways towards pharmaceutical opportunities using sophisticated cell culture and animal models.
Associate Professor of Pharmacology and Medicine (Hematology and Oncology)
The Liu lab studies the molecular mechanisms underlying cancer stem cells (CSCs) and metastasis through four ongoing interactive basic and translational research projects: (1) to understand CSCs in metastasis using cutting-edge single cell sequencing and CRISPR/Cas9 gene editing technologies; (2) to image CSC behavior and interactions with immune cells during metastasis using bioluminescence imaging and intravital imaging systems; (3) to target CSCs with novel therapeutics delivered by exosomes and nanoparticles; (4) to develop circulating tumor cells (CTCs) and circulating exosome-based bioma...
Professor of Medicine (Hematology and Oncology)
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Clinical trials
Associate Professor of Medicine (Hematology and Oncology)
The diagnosis and treatment of bleeding disorders and their complications. Evaluation of causes of thrombosis and education regarding treatment and prevention of thrombosis.
Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics
chronic leukemias, multiple myeloma, non-hodgkin's lymphoma
Professor of Medicine (Hematology and Oncology)
My clinical domain is breast cancer management. My clinical research interest focuses on the development of novel therapies for the treatment of breast cancer. Clinical trials focusing on precision medicine for defining the right therapy, for the right patient at the right time is our goal. To that end, molecular interogation of breast tumors are leading to novel trial design that will hopefully translate into better outcomes for our patients. In conjuction with the developmental therapeutics program, novel agents are being incorporated into clinical trials for patients with both early and lat...
Professor of Medicine (Hematology and Oncology)
Myeloma, Transplantation
Assistant Professor of Medicine (Hematology and Oncology)
Dr. Jonathan Moreira is an Assistant Professor of Medicine in the Department of Medicine, Division of Hematology/Oncology at Northwestern University’s Feinberg School of Medicine. After receiving dual bachelor degrees at the University of Illinois at Urbana-Champaign, he returned to his native Chicago, where he received a medical degree from Loyola University Chicago’s Stritch School of Medicine. He then went on to complete a residency in Internal Medicine at Mayo Clinic in Rochester, Minnesota. He returned to Chicago to complete a fellowship in Hematology/Oncology at Northwestern University’s...
Assistant Professor of Medicine (Hematology and Oncology)
Dr. VanderWeele did his medical and research training at the University of Chicago, where he developed a research program characterizing the heterogeneity and evolution of the cancer genome. He moved to the National Cancer Institute in Bethesda, MD, where he continued to seek to improve the treatment of prostate cancer based on patients’ specific genetic changes. He returned to Chicago in 2018 to join the GU cancer team at Northwestern University, where he continues to translate discoveries made at the bench into improved therapies in the clinic.
Diversity and Inclusion
The department works toward an environment of inclusion and support through the Diversity and Cultural Affairs Council and through several dedicated events and initiatives.
Housestaff Research Portal
Physician-Scientist Training & Resources
We offer a wide range of resources, mentorship opportunities and formal training programs to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.
Giving
Support What We Do
We invite your philanthropic partnership in helping us achieve our research and teaching missions each day.
Contact Terri Dillon for more information on supporting the Division of Hematology-Oncology at 312-503-4837 or terri-dillon@northwestern.edu.